Tiaki Therapeutics ^Company

Tiaki Therapeutics is committed to developing microglia-targeted therapeutics for the treatment of dementias. Tiaki is at the forefront of harnessing microglial function. Using insights from academia, Tiaki is developing a platform to discover small molecule therapeutics which will restore microglial function in the aging brain. Tiaki is funded by the Dementia Discovery Fund, a venture capital fund which invests in projects and companies to discover and develop novel, effective, disease-modifying therapeutics for dementia.